Open original FDA record ↗Recall record
- FDA identifier
- Z-1707-2014
- Company in FDA record
- Brainlab AG
- FDA classification date
- Jun 3, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
When using a specific plan update workflow in combination with a non-Brainlab treatment planning system (TPS), there is a possibility in ExacTrac 5.5.5 to generate an unintended blend of two initially separate plans of the same patient.
Source facts
- Action
- Brainlab sent a "FIELD SAFETY NOTICE / PRODUCT NOTIFICATION" letter dated March 13, 2014 was sent to all affected customers. The letter identifies the affected product, problem, and actions to be taken. The letter includes specific instructions to users that are intended to reduce the likelihood of similar events occurring when using ExacTrac software version 5.5.5. The letter further states that Brainlab will be providing a software update to all customers. Brainlab will contact all customers to arrange for the software update within the following 6 months. Customers with any questions about this issue can contact Brainlab at 800-597-5911 or via e-mail at us.support@brainlab.com.
- Initiated
- 2014-04-15
- Root cause
- Software design
- Terminated
- 2017-04-24
- Distribution
- Worldwide Distribution - US Nationwide in the states of AZ, AR, CA, FL, KY, MA, NE, NY, TN, TX and the countries of Argentina, Australia, Brazil, Finland, India, Japan, Netherlands, Oman, Russia, and Taiwan
- Recall number
- Z-1707-2014
- Recall status
- Terminated
- CDRH record ID
- 126619
- FDA classified
- 2014-06-03
- Recall event number
- 67926